Transcript Characteristics of Leading Roadside Drug Screening

10. Jubilarna Međunarodna Konferencija | 10th Jubilee International Conference
BEZBEDNOST SAOBRAĆAJA U LOKALNOJ ZAJEDNICI
ROAD SAFETY IN LOCAL COMMUNITIES
Kragujevac, 22-25. April, 2015.
City of Kragujevac, April 22-25, 2015.
Role of Drug Screening Technology to Improve European
Road Safety
Mark L. Johnson
Contents
Road Accidents in the European Union
Socio-Economic Impact of Road Accidents
Potential Consequences of Drug Driving
Characteristics of Leading Roadside Drug Screening Devices
Results: Effective Technology to Reduce Drug Driving
Fatalities
Securetec AG
Road Accidents in the European Union
EU Safety Action Programme (2003) to halve road fatalities by 2010 was
almost fully achieved. New Target: Reduce further 50% by 20201
²
1. Towards a European road safety area, policy orientations on road safety 2011-2020, European Commission, page 4
2. DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme 2011-2020, Final Report, European Commission February 2010, page 5
3
Road Accidents in the European Union:
Fatalities per Million
Road Accidents in the European Union
Road Fatalities per Million
Inhabitants in 2006
Gap between the best and
worst performing Member
State is large with the best
performing 4 times better
than the worst
DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme 2011-2020, European Commission, Final Report, February 2010, page 8
4
Socio-Economic Impact of Road Accidents
Socio-Economic Impact of Road Accidents
The estimated socio-economic costs in Europe are around €180
billion comprising 2% of GDP1
The annual motor vehicle accident costs are approximately 20
billion Euros in the UK alone²
The large number of road traffic deaths and injuries represents a
substantial burden for the health sector in Member States³
1.
2.
3.
DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme 2011-2020, European Commission, Final Report, February 2010 , page i
Baker Tilley report for Institute of Advanced Motoring, October 4th, 2011, http://www.mansgreatestmistake.com/the-true-cost-of-cars/annual-motor-vehicle-accident-costs
DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme 2011-2020, , European Commission, Final Report, February 2010 , page 5
5
Potential Consequences of Drug Driving
Potential Consequences of Drug Driving
The use of illicit drugs and some
medicines, is an increasingly
worrying factor in road
accidents…
If nothing is done urgently,
there could soon be more
accidents due to drugs than to
alcohol.
Different measures will have to
be taken e.g.:
 Establishment of a harmonised
procedure to detect illicit drugs in drivers
 Development of detection equipment…
SAVING 20 000 LIVES ON OUR ROADS, EUROPEAN ROAD SAFETY ACTION PROGRAMME, Halving the number of road accident victims in the European Union by 2010: A shared responsibility
COMMUNICATION FROM THE COMMISSION COM(2003) 311 final, pages 20 & 21
6
Characteristics of Leading Roadside Drug
Screening Devices
Why Test Oral Fluid?
 Saliva collection is much
less invasive than urine
collection
Comparison of detectable THC traces in
blood, saliva, urine after consumption
 When test person is not
controlled during urine
collection, sample can be
manipulated and falsified
 Saliva sample reveals
recent drug use
Most often, legislation in
Europe dictates: Saliva is
tested at the roadside, blood
for confirmation
7
Characteristics of Leading Roadside Drug
Screening Devices
The DRUID STUDY
Sponsored by the European Commission, police officers evaluated failure
rate, operability hygiene and technical performance of the most common
oral fluid rapid tests - 36 institutions from 18 countries participated
The study took place from 2006 – 2009
All data were independently gathered and assessed by Police and
Universities in the EU and are publicly available
The DRUID Study was defined in two parts:
 Part I: ESTHER – Evaluation of Easy Operation
 Part II: DRUID – Scientific Evaluation of Reliability
http://www.druid-project.eu
8
ESTHER (Evaluation of oral Fluid Drug Screening devices by TISPOL to Harmonise European police Requirements
DRUID (Driving under the Influence of Drugs)
Roadside Drug Screening Practice in Europe:
DRUID Study Highlights
Characteristics of Leading Roadside Drug
Screening Devices
Part I “ESTHER” on Practicability (2006 – 2009)
9
Roadside Drug Screening Practice in Europe:
DRUID Study Highlights
Characteristics of Leading Roadside Drug
Screening Devices
Part II “DRUID” Scientific Evaluation (2008 – 2009)
Accuracy = 93%
Solutions based
on electronic
readers
Druid Project Deliverable 3.2.1 from 8.12.2009 National Institute for Health and Welfare, Finland.
10
Characteristics of Leading Roadside Drug
Screening Devices
Characteristics of Leading Roadside Drug
Screening Devices
Results in 3 to 8 minutes
Very high sensitivity, specificity and
accuracy
Simple, fast and hygienic sampling
(saliva)
Very small saliva sample (e.g. obtainable
in seconds, not minutes)
Clear visible test lines
Small, portable, robust, and versatile
products (e.g. saliva, sweat, surfaces)
No electronics necessary: Handheld
electronic reading devices can be used as
an option
11
Results: Effective Technology to Reduce
Drug Driving Fatalities
Case Study in Australia
Campaign: “Drivers tested: anybody, anywhere, anytime” reduced
percentage of drug drivers involved in fatal accidents by half
2003 - 31% of drivers involved in fatal accidents tested positively for drugs
2004 - the Australian federal state of Victoria was the first region
worldwide to establish a legal basis for drug control of vehicle operators
which is not dependent on cause for suspicion
The entire street is blocked and all drivers are tested for alcohol and drugs
For Drug Screening, Securetec’s DrugWipe® is applied
2005 - 25% of the drivers who were involved in severe traffic accidents,
tested positively for illegal drugs
2009 – Only 15%
•
•
www.police.vic.gov.au/policelife & www.tacsafety.com.au/campaigns/drug-driving
5th Australasian Drug Strategy Conference , Melbourne, Victoria in March 2010
12
Introduction to Securetec AG
Securetec AG
Founded 1995
45 Employees
Located near Munich, Germany
Subsidiaries in the U.S. and in France
Detecting up to 6 Drug
Substances Simultaneously
Leading in the area of drug detection with
worldwide sales in more than 30 countries
on 5 continents
In-house Research and Development
Certified according to international
standard ISO 9001 for quality management
and the standard EN ISO 13485 for medical
devices
13
Conclusion
EU member states and institutions widely recognize that drug
driving significantly contributes to traffic accidents
Several EU member states have already launched roadside drug
screening programs which aim to reduce traffic accidents
Technology can enable drug screening: There are devices available
which are very easy-to-use and highly reliable
Cooperation between industry and traffic police can only be
achieved via national political will and relevant legislation
10. Jubilarna Međunarodna Konferencija | 10th Jubilee International Conference
BEZBEDNOST SAOBRAĆAJA U LOKALNOJ ZAJEDNICI
ROAD SAFETY IN LOCAL COMMUNITIES
Kragujevac, 22-25. April, 2015.
City of Kragujevac, April 22-25, 2015.
THANK YOU FOR YOUR ATTENTION …